William Fry LLP has an evenly balanced practice with strength in both healthcare and life sciences. It remains active in clinical, professional and product liability claims before all courts, along with patent litigation and product liability disputes in the pharmaceutical, biotech and medical device sectors. It has an established team in the life sciences regulatory sphere and an outstanding record in life sciences M&A (including headline cross-border transactions) and commercial work. Laura Scott heads the life sciences team and is a leader in patent disputes, with Charleen O’Keeffe and Colette Brady also having extensive experience in the area. Margaret Muldowney and Fiona Barry are experienced figures in clinical negligence and Mary Cooney is noted for product liability cases.
Legal 500 redaktioneller Kommentar
Anwält*innen
Leading partners
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Next Generation Partners
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Praxisleitung
Margaret Muldowney; Laura Scott
Weitere Kernanwält*innen
Charleen O’Keefe; Colette Brady; Fiona Barry; Mary Cooney; Barry Murphy